StockData
CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

CERUS CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$2.22+0.04 (+1.83%)

Close on Oct 19, 2026

Market cap
$445.25M
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 5, 2026, during market hours (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 30, 2026During market hours$63.30M$-0.01–
Q1 FY2026
Ended Mar 31, 2026
Apr 30, 2026During market hours$59.90M$-0.01–
Q4 FY2025
Ended Dec 31, 2025
Mar 2, 2026During market hours$64.60M$-0.01–
Q3 FY2025
Ended Sep 30, 2025
Nov 6, 2025During market hours$60.20M$0.00–
Q2 FY2025
Ended Jun 30, 2025
Aug 5, 2025During market hours$60.10M––
Q1 FY2025
Ended Mar 31, 2025
May 1, 2025During market hours$48.90M$-0.04–
Q4 FY2024
Ended Dec 31, 2024
Feb 20, 2025During market hours$56.75M$-0.01–
Q3 FY2024
Ended Sep 30, 2024
Oct 30, 2024During market hours$50.66M$-0.02–
Q2 FY2024
Ended Jun 30, 2024
Aug 1, 2024During market hours–––
Q1 FY2024
Ended Mar 31, 2024
May 2, 2024During market hours–––
Q4 FY2023
Ended Dec 31, 2023
Mar 5, 2024During market hours–––

Company guidance

Outlook given with results on Jul 30, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
IFC revenuefull-year 2026$23.00M to $25.00MLowered
product revenuefull-year 2026$229.00M to $231.00MRaised
product revenue growthfull-year 202611% to 12% growthRaised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Cerus filed with the SEC